1. Home
  2. CMPS vs VALU Comparison

CMPS vs VALU Comparison

Compare CMPS & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • VALU
  • Stock Information
  • Founded
  • CMPS 2020
  • VALU 1931
  • Country
  • CMPS United Kingdom
  • VALU United States
  • Employees
  • CMPS N/A
  • VALU N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • VALU Investment Managers
  • Sector
  • CMPS Health Care
  • VALU Finance
  • Exchange
  • CMPS Nasdaq
  • VALU Nasdaq
  • Market Cap
  • CMPS 364.9M
  • VALU 384.1M
  • IPO Year
  • CMPS 2020
  • VALU N/A
  • Fundamental
  • Price
  • CMPS $4.59
  • VALU $38.27
  • Analyst Decision
  • CMPS Strong Buy
  • VALU
  • Analyst Count
  • CMPS 7
  • VALU 0
  • Target Price
  • CMPS $18.83
  • VALU N/A
  • AVG Volume (30 Days)
  • CMPS 1.1M
  • VALU 2.6K
  • Earning Date
  • CMPS 07-31-2025
  • VALU 07-25-2025
  • Dividend Yield
  • CMPS N/A
  • VALU 3.40%
  • EPS Growth
  • CMPS N/A
  • VALU 17.96
  • EPS
  • CMPS N/A
  • VALU 2.28
  • Revenue
  • CMPS N/A
  • VALU $35,695,000.00
  • Revenue This Year
  • CMPS N/A
  • VALU N/A
  • Revenue Next Year
  • CMPS N/A
  • VALU N/A
  • P/E Ratio
  • CMPS N/A
  • VALU $16.70
  • Revenue Growth
  • CMPS N/A
  • VALU N/A
  • 52 Week Low
  • CMPS $2.49
  • VALU $32.94
  • 52 Week High
  • CMPS $8.54
  • VALU $57.68
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 64.81
  • VALU 43.91
  • Support Level
  • CMPS $3.86
  • VALU $38.15
  • Resistance Level
  • CMPS $4.52
  • VALU $39.50
  • Average True Range (ATR)
  • CMPS 0.36
  • VALU 0.68
  • MACD
  • CMPS 0.00
  • VALU -0.14
  • Stochastic Oscillator
  • CMPS 65.63
  • VALU 13.17

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

Share on Social Networks: